Company News »

Marrone Bio Innovations Receives NASDAQ Notice Regarding Late Form 10-K Filing

Business Wire
Share on StockTwits
Published on

Marrone Bio Innovations, Inc. (MBI)(NASDAQ:MBII) today announced that, as anticipated, it has received a letter from the Listing Qualifications Department of The NASDAQ Stock Market LLC (“NASDAQ”) notifying MBI of its noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company’s filing of a Notification of Late Filing on Form 12b-25 on April 1, 2015. In the Form 12b-25, the company indicated that the filing of its Annual Report on Form 10-K for the year ended December 31, 2014 (the “Form 10-K”) will be delayed until after the completion of Company management’s evaluation of the necessity, nature and scope of any restatements to its previously filed financial statements. The NASDAQ letter states that the Company is required to submit, no later than April 17, 2015, an update to its plan to file any delinquent reports by May 13, 2015 and to regain compliance with NASDAQ’s filing requirements for continued listing.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this release may constitute “forward-looking statements and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding the Company’s financial statements and regaining full compliance with NASDAQ continued listing requirements. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include uncertainty surrounding management’s evaluation of the nature and scope of any necessary restatements to its previously filed financial statements, the types of errors and adjustments that may be required in any such restatement, potential legal or regulatory action related to the matters under investigation, and adverse decisions by the SEC or NASDAQ. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Share on StockTwits